PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/9/2004
PHARMANIAGA BERHAD |
Quarterly report for the financial period ended | 30/09/2004 |
Quarter | 3 |
Financial Year End | 31/12/2004 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/09/2004 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/09/2004 | 30/09/2003 | 30/09/2004 | 30/09/2003 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 229,265 | 156,200 | 599,214 | 465,987 |
2 | Profit/(loss) before tax | 22,581 | 16,917 | 59,514 | 48,177 |
3 | Profit/(loss) after tax and minority interest | 14,201 | 11,226 | 37,467 | 31,261 |
4 | Net profit/(loss) for the period | 14,201 | 11,226 | 37,467 | 31,261 |
5 | Basic earnings/(loss) per share (sen) | 13.99 | 11.21 | 37.06 | 31.24 |
6 | Dividend per share (sen) | 0.00 | 0.00 | 0.00 | 0.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net tangible assets per share (RM) | 2.5300 | 2.2200 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 26 Nov 2004 |
Category | Financial Results |
Reference No | CC-041126-51E6F |